Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study. - Wikidata - wikimedia - TriplyDB

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.

http://www.wikidata.org/entity/Q35558983

about

Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis Body weight management in overweight and obese breast cancer survivors The Obesity-Breast Cancer Conundrum: An Analysis of the Issues Breast cancer survival among young women: a review of the role of modifiable lifestyle factors Body mass index and weight change in relation to triple-negative breast cancer survival.Inhibitory effects of BMP9 on breast cancer cells by regulating their interaction with pre-adipocytes/adipocytes.Metabolic syndrome in breast cancer.The role of adiponectin in cancer: a review of current evidence.Progranulin as a prognostic biomarker for breast cancer recurrence in patients who had hormone receptor-positive tumors: a cohort study.Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?Circulating adiponectin and breast cancer risk: a systematic review and meta-analysis.Resistin, visfatin, adiponectin, and leptin: risk of breast cancer in pre- and postmenopausal saudi females and their possible diagnostic and predictive implications as novel biomarkers.Metabolic syndrome and triple-negative breast cancer: a new paradigm.Impact of Weight Loss on Plasma Leptin and Adiponectin in Overweight-to-Obese Post Menopausal Breast Cancer Survivors Peroxisome proliferator-activated receptor gamma (PPARG) polymorphisms and breast cancer susceptibility: a meta-analysis.Pre-diagnosis body mass index and survival after breast cancer in the After Breast Cancer Pooling Project.Contribution of uric acid to cancer risk, recurrence, and mortality.Association Between Insulin Resistance and Luminal B Subtype Breast Cancer in Postmenopausal Women.Homeostasis model assessment to detect insulin resistance and identify patients at high risk of breast cancer development: National Cancer Institute of Naples experience.Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women Sex-specific associations between body mass index, waist circumference and the risk of Barrett's oesophagus: a pooled analysis from the international BEACON consortium Modified metabolic syndrome and second cancers in women: A case control study.Effects of a physical activity behavior change intervention on inflammation and related health outcomes in breast cancer survivors: pilot randomized trial Advanced Hepatic Fibrosis in Fatty Liver Disease Linked to Hyperplastic Colonic Polyp.Leptin and breast cancer: an overview.Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms.Insulinemia and the risk of breast cancer and its relapse.Metabolic syndrome in patients with hematological diseases.Triple-negative breast cancer: new perspectives for novel therapies.Adiponectin and its receptor signaling: an anti-cancer therapeutic target and its implications for anti-tumor immunity.Impact of metabolic syndrome on the survival of Chinese patients with resectable esophageal squamous cell carcinoma.BMI variation increases recurrence risk in women with early-stage breast cancer.Effect of metabolic syndrome and its components on recurrence and survival in early-stage non-small cell lung cancer.The tetrad BMI, leptin, leptin/adiponectin (L/A) ratio and CA 15-3 are reliable biomarkers of breast cancer.Triple-negative breast cancer and its association with obesity.A prospective evaluation of clinical and genetic predictors of weight changes in breast cancer survivors.Obesity-associated Breast Cancer: Analysis of risk factors.Relationship of serum isoflavone, insulin and adiponectin levels with breast cancer risk.

P2860

Q23920590-C7E03F10-5054-4EC5-8841-65C73D0777A0 Q24186086-BFFB2D68-7D3F-4621-ABE5-D4C8EC06FD10 Q26747486-701779FA-87CD-4741-8C61-DC33CD02F5E2 Q26766205-E865B3B1-1CB3-4AFF-AD48-24A487E17515 Q33712501-4925B566-A94E-4E8E-873D-C97810CEA2F9 Q33829349-98D99A08-5D43-4AC2-B83E-22D80B72A63B Q33973037-1FBD44D4-9D25-4398-820A-7D1200CEDFD4 Q34271986-7E447ABB-0494-43E7-A8B8-D97B18381065 Q34326604-C752F956-12EB-4A02-A96D-28630BA33A25 Q34572361-4CDB938B-CDBD-47CD-BFAA-04481C359E7C Q34649283-0F27315C-91D1-49C3-B162-E6791AF0AB74 Q35206787-F79BC2BF-E9B9-4E63-B264-5D64782C60BD Q35684565-314164F6-F267-4A01-8695-B03F092C9D7E Q35894947-9DBF63E6-4D22-475F-821D-590920653810 Q36182663-C0389E1C-F982-4F8C-B4C5-E9F5C771C95B Q36426540-385D0A91-9E26-47D4-BE1E-3AC8EBD508F8 Q36578207-CE8A268D-734E-43AB-AB24-E20146807D35 Q36663869-A4C6A7E4-57DA-4EF7-BE25-4452FCEF2CAD Q36755540-E88BF4D2-008E-4EDC-8ACB-AB1937426EEF Q36894869-588733F7-561F-43B1-9CF7-4B7A88A6AA53 Q37297394-7E155218-C1BC-4ED7-B34D-FD5F448F4B04 Q37532299-D112961D-AD42-4F7B-95C3-3B594A953C31 Q37539995-3FDB75E0-3184-46DD-833B-2AE7523EACEA Q37588703-A6A23E02-BE18-46DF-AA82-E378BD9559F4 Q37923859-346EADF6-2042-4277-83FE-6DCF35DAD60D Q37963505-DCA598F4-82A9-4D3D-AA48-117B49EA0784 Q38005770-8C12D0A0-9962-4846-B982-CADEF335FA04 Q38044776-0F2FBE54-C278-420F-8FA2-96CA649B2016 Q38119171-7D2B3B27-3FA5-4155-BC24-1FA7890A990E Q38465754-A31D6C3D-DD4A-49E3-B5A5-7D4BA01AE1AA Q38540337-5BC89886-9DA3-407C-ADB5-0C5932D9F0E8 Q39070938-2C48182E-AC80-4FFF-BECB-621FF98BD766 Q41725990-EE97DEA5-18F4-4210-B3AA-9C5D5AF519CA Q44151520-1BFDBB53-A044-4504-ACB2-043287B1F3AB Q47099775-DCE1EBFB-BFDA-4873-AF8E-76CE1148F6BA Q47235598-5AD742D2-D817-4C13-AF3A-10C1E1AD1FD7 Q50957755-35B812CE-36DE-4CAF-A68A-F28D5C81EC1C Q54684671-9BEB361E-7B50-40D7-85AC-E244841E6888

P2860

Adipokines, insulin resistance, metabolic syndrome, and breast cancer recurrence: a cohort study.

http://www.wikidata.org/entity/Q35558983

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@ast

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@en

type

label

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@ast

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@en

prefLabel

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@ast

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@en

P1433

Q35558983-053D030D-C1AF-4D8D-8C4D-0CF5816DCBC1

P1476

Q35558983-D0C9E92E-75A5-40F6-8B88-EA92313886C0

P2093

Q35558983-15F5FE21-ADA3-4995-991C-04C174BFF232

Q35558983-18DCC74C-2986-4EE3-9D7B-41FD8FCE4EBF

Q35558983-1BC93737-6385-4ACC-A92B-AAFA8EF96DD4

Q35558983-29EB2D4C-9164-41EA-A286-02348BDFF5B8

Q35558983-34EA0106-02C5-4541-8345-73D360009267

Q35558983-614CBF76-4F7A-417F-8A6D-FD4771B2EB89

Q35558983-B9D77977-1875-4ED6-A3DA-CFE46DD4C154

Q35558983-CFA13AC2-9830-4E0D-B90D-47C540AFDE84

Q35558983-D44AE4C6-8F8D-4B93-8514-EF009D74FF71

Q35558983-D85E396A-D228-444F-B6C0-5C92AD414468

P2860

Q35558983-04C7FDBF-801C-4B3C-818A-7C9CBEC4E23B

Q35558983-07599B46-B3DB-472F-BE98-8F2D5BFD9EBF

Q35558983-090445B7-11FE-4FEF-B9C3-0C16BA9A3429

Q35558983-0AFAADEF-B456-4F23-92C8-32DC69EE0ECD

Q35558983-1218444D-0F3E-4275-9060-BEFE9885B12D

Q35558983-15DAEF13-D4B2-48B5-80C3-1B9258151635

Q35558983-3867D0F3-E24C-4E27-977C-99C4B2C05FEA

Q35558983-3CCBD1FE-7036-4195-9174-0D8E242CE223

Q35558983-50DC9F1E-5BD7-471D-829B-C5124233056F

Q35558983-54CC2B01-399A-4306-AAB2-11523C4C6F13

P2888

Q35558983-F754A687-25EE-478B-B94D-F7D495F9C86A

P304

Q35558983-E2BDC622-5FAD-42CC-AD7D-B7E72709B2CF

P31

Q35558983-B4BF19F0-B972-4F0D-9158-FC1FC784E24B

P356

Q35558983-EE380E74-338B-436E-A987-860004069D3C

P433

Q35558983-7C9C035C-719E-4055-AE11-EE0A9B35489A

P478

Q35558983-20C3A3EE-84E7-4D38-A8E1-B35B85F6EFB2

P50

Q35558983-4A305F0E-3912-4D9F-B21A-8050E70DE29A

P577

Q35558983-615901C3-1306-482F-9AB7-63922F33CA3E

P5875

Q35558983-FEE9E8A1-DCF3-4951-A2DF-0BD738CF9D6A

P6179

Q35558983-5C5AB0D8-AC31-4A82-9612-6056B01381B2

P698

Q35558983-88D77B91-5765-4163-BF83-3B35F3540D53

P921

Q35558983-8889F000-008D-4D2D-8863-25C53EB58085

P932

Q35558983-74BB7E41-5391-4135-A95D-321271A6D9C2

P356

P1433

Breast Cancer Research

P1476

Adipokines, insulin resistance ...... er recurrence: a cohort study.

@en

P2093

Cheol-Young Park

http://www.w3.org/2001/XMLSchema#string

Eon Sook Lee

http://www.w3.org/2001/XMLSchema#string

Eun Sook Lee

http://www.w3.org/2001/XMLSchema#string

Han Sung Kang

http://www.w3.org/2001/XMLSchema#string

Jungsil Ro

http://www.w3.org/2001/XMLSchema#string

Keun Seok Lee

http://www.w3.org/2001/XMLSchema#string

Nak Jin Sung

http://www.w3.org/2001/XMLSchema#string

Sang Woo Oh

http://www.w3.org/2001/XMLSchema#string

Yeong Sook Yoon

http://www.w3.org/2001/XMLSchema#string

Young Ho Yun

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Adipose tissue as an endocrine organ

Metabolic syndrome and postmenopausal breast cancer in the ORDET cohort: a nested case-control study

Adiponectin and breast cancer risk.

Predictive markers in breast and other cancers: a review.

Adiponectin and cancer: a systematic review

Molecular links between obesity and breast cancer.

P2888

P304

R34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR2856

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

13

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

50935625

http://www.w3.org/2001/XMLSchema#string

P6179

1013448407

http://www.w3.org/2001/XMLSchema#string

P698

21450081

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

P932

3219197

http://www.w3.org/2001/XMLSchema#string